CHAIRMAN & PRESIDENT
Michael Donahue is Founder and President of Columbia Capital Advisors, Inc. and Columbia Capital Securities, Inc. He is a corporate and securities lawyer, corporate advisor and investment banker working with emerging growth and middle market companies focusing on assisting them in raising capital and developing the business’ ability to raise capital. This includes equity and debt financings, private placements, venture capital, private equity, initial and secondary public offerings, PIPEs, alternative going public strategies including reverse mergers and financings coupled with reverse mergers. Mr. Donahue is a frequent speaker at conferences on these strategies.
He is the Founder and President of Columbia Capital Securities, Inc. He manages its investment banking operations and works with clients on raising capital and mergers and acquisitions. Michael Donahue is Founder and President of Columbia Capital Advisors, Inc. where he provides financial consulting services to companies in developing what they need to enhance value and raise capital or to sell the company. He focuses on innovative and alternative strategies for raising capital.
Mr. Donahue is a corporate and securities lawyer previously with several firms including Holland & Knight LLP and Richardson & Patel LLP where he has guided corporate clients on capital financings and the legal and regulatory requirements for publicly-traded companies. He has represented public and private companies, investment banking and other securities firms, investment advisory firms and investment funds focusing on public and private offerings and SEC and FINRA regulatory matters.
Mr. Donahue started his career as an attorney with the United States Securities and Exchange Commission (“SEC”) in its Division of Enforcement and Division of Corporation Finance in Washington, D.C. and was a Branch Chief, Enforcement in the SEC Los Angeles Regional Office.
Mr. Donahue is Chairman of the Corporate Capital Forum, Inc. which presents conferences on raising capital for emerging growth companies. Mr. Donahue has been active in organizing and speaking at conferences on raising capital for several years and has been a speaker at over 60 conferences in the past several years. He was a co-founder of the Investment Capital Conference presented by the Los Angeles Venture Association and served as its Chairman for 11 years. Under his leadership, the Investment Capital Conference grew to become one of the largest non-profit conferences in the country on financing high growth companies. He was Co-Chairman of the World Capital Conference in China focusing on Chinese companies raising capital and going public in the United States.
Roger Zickfeld is a Managing Director of Columbia Capital Advisors, Inc. and Columbia Capital Securities, Inc. He has extensive experience as a senior corporate executive, investment banker and consulting executive with a diverse skill set and domain expertise in the medical device, pharmaceutical and diagnostics industries.
He was previously an investment banker and Managing Director with Salem Partners and B. Riley & Co., Inc., where he was a senior medical device and pharma investment banker providing strategic advisory services, private placements, PIPEs and M&A services. He was a Managing Director with Coldwater Associates, LLC, a boutique corporate strategy and capital advisory firm focused on emerging technology and life sciences companies.
Mr. Zickfeld held several senior executive positions with Karl Storz Endoscopy, including President of the Extracorporeal Lithotripsy Division, Senior Vice President and corporate level Chief Financial Officer, President of a captive sales division and Vice President, Finance and Administration. Karl Storz is a $1 billion+ revenue medical device company.
He also had executive experience in emerging companies as CEO of Gene Connections, a gene discovery technology venture spin-off from UCLA, Executive-in-Residence with Slo Media Incubator and COO of StreamExchange.com. Mr. Zickfeld was Manager, General Management Consulting Group of KPMG. Prior to this he was a Supervising Senior with Ernst & Young.
He received a B.S., Magna cum Laude, Business Administration from University of Southern California and an M.B.A. from the UCLA Anderson School of Management.
Olivier Jarry is a Senior Advisor of Columbia Capital Advisors, Inc. and Columbia Capital Securities, Inc.
He has extensive experience as a senior corporate executive and consulting executive with a diverse skill set and domain expertise in the pharmaceutical, medical devices and diagnostics industries.
In life sciences, he has led regional businesses in the Americas, Europe and Asia as well as global divisions, with sales from startup stage and up to $1.5 billion, mainly for Novartis, Bayer, Bristol-Myers Squibb. Therapeutic areas covered included diabetes and metabolism, oncology, immunotherapies, vaccines, virology and infectious diseases, mother and child health.
He has also managed and completed several dozen acquisitions and divestitures totaling $2 billion in value and negotiated alliances generating revenues of several hundred million dollars annually. These alliances have included companies such as Danone, Mitsubishi, Pfizer, Panasonic Healthcare, and Daiichi-Sankyo.
Mr. Jarry is on the Board of several companies such as LIFNano, a biotech in neuroscience, Fit4D in diabetes coaching, Rimidi, in population management, Dario Health, in diabetes monitoring, Skipta Inc., a platform for physicians collaboration.
He was an Associate Partner for Accenture in Europe, and started their post-merger integration practice.
Mr. Jarry is based in New York and has clients in North America, Europe, Asia, and South America.
He received a TRIUM executive MBA jointly from NYU Stern, London School of Economics and HEC Paris. He also has a M.Sc. from Ecole Centrale de Paris and a M.Eng. from the French Defense Ministry.
23+ YEARS OF ENTERTAINMENT INDUSTRY EXPERIENCE AS AN INVESTMENT BANKER, LAWYER, PRINCIPAL INVESTOR AT A MULTI-BILLION DOLLAR ALTERNATIVE ASSET MANAGEMENT FIRM AND SENIOR FINANCIAL EXECUTIVE AT A MAJOR STUDIO.
20+ YEARS OF EXPERIENCE IN FILM, MUSIC AND TELEVISION INDUSTRIES INVESTMENT BANKING, INCLUDING PRIVATE PLACEMENTS, VALUATIONS, STRATEGIC ADVISORY, SELL/BUY-SIDE MERGERS AND ACQUISITIONS, RESTRUCTURING, FINANCIAL DUE-DILIGENCE, MARKET-SIZING, FILM GROSS/PROFIT PARTICIPATIONS AND FINANCIAL MODELING.
20+ YEARS OPERATING EXPERIENCE IN THE TELEVISION, FILM AND DIGITAL MEDIA INDUSTRIES. HAS RUN MAJOR TV STUDIOS FOR CBS AND FOX, AND HAD SENIOR LEVEL PROGRAMMING POSITIONS AT MTV AND OXYGEN.
INVESTMENT BANKING ASSOCIATE
Aron Heikali is an associate investment banker with Columbia Capital Securities, Inc., where he focuses on mergers and acquisitions, selling businesses, and raising capital for businesses.
He has experience both as an investment banker in carrying out these transactions for clients and on the investor side in assisting an investment firm with its acquisitions.
Prior to joining Columbia Capital Securities, Mr. Heikali worked as an associate with Riverbrook Capital, a boutique investment bank serving middle market clients with corporate finance and M&A transactions. Prior to his work at Riverbrook, he was an investment associate at Castle Capital, a middle market private equity firm where he evaluated candidate businesses for the firm’s leveraged buyout portfolio and worked on potential transactions in the waste, recycling, manufacturing, and healthcare industries. Prior to that, he worked as an investment banking analyst at Clear Capital Advisors, a boutique technology- and healthcare-focused middle market investment bank, and held other roles in investment banking at both CB Capital Partners and Gemini Partners (now “Drake Star Partners”).
In his spare time, Mr. Heikali enjoys weight lifting and practicing his baroque and classical repertoire on the piano. He is also an avid reader, with strong interests in economic history and regenerative medicine. Conversational in both Farsi and Spanish, Aron’s dormant language abilities also include Hebrew and rudimentary Mandarin (Chinese).
Mr. Heikali is a graduate of the University of Southern California, where he earned a B.A. in Economics, B.S. in Accounting, and B.S. in Business Administration. He is a member of the International Business Brokers Association (IBBA), holds the organization’s Certified Business Intermediary (CBI) designation, and holds the Certified M&A Professional (“CM&AP”) designation. He is also a Chartered Financial Analyst (CFA) Level III candidate and is currently licensed with FINRA as an Investment Banking Representative (Series 79 and Series 63).